ÀüÀ̼º ¹æ±¤¾Ï ȯÀÚÀÇ M-VAC (Methotrexate, Vinblastin, Adriamycin, Cisplatin) º´¿ë ¿ä¹ý
M-VAC Combination Chemotherapy in Advanced Bladder Cancer
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°æ¼·/Lee KS
±èõÀÏ/À̼ºÁØ/Kim CI/Lee SC
KMID : 0358319870280010074
Abstract
Patients with advanced carcinoma of the bladder that relapses or persists after conventional therapy have a poor prognosis. The management of the patient with
recurrent local or disseminated bladder cancer presents a difficult clinical problem. In l985, Sternberg et al reported 7l% significant tumor regression and 50% complete clinical remission with M-VAC(Methotrexate, Vinblastin, Adriamycin and Cisplatin) combination chemotherapy for treatment of advanced bladder carcinoma Herein, we report 4 cases of M-VAC combination chemotherapy in far advanced bladder carcinoma with had measurable metastatic lesions enough to evaluate the objective response of chemotherapy.
Å°¿öµå
¹æ±¤Á¾¾ç; ÈÇпä¹ý; bladder cancer; chemotherapy; M-VAC
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸